Ameritas Investment Partners’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-11
Closed -$13K 3089
2018
Q1
$13K Hold
11
﹤0.01% 2640
2017
Q4
$10K Hold
11
﹤0.01% 2761
2017
Q3
$12K Hold
11
﹤0.01% 2716
2017
Q2
$13K Buy
+11
New +$13.4K ﹤0.01% 2718

Other funds holding HSTO

Ameritas Investment Partners's HSTO Position: Q2 2018 in Review

Ameritas Investment Partners sold out of Histogen Inc. Common Stock (HSTO) in Q2 2018, closing a stake of 11 shares — an estimated $13K sold.

Ameritas Investment Partners first reported a position in HSTO in Q2 2017 and held it in 4 quarters. The position peaked at $13K in Q1 2018. 61 funds tracked by Wall St. Rank hold HSTO as of Q2 2018.

  • Ameritas Investment Partners reported no remaining Histogen Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Ameritas Investment Partners sold 11 Histogen Inc. Common Stock shares in Q2 2018, an estimated $13K.
  • Ameritas Investment Partners first reported a position in Histogen Inc. Common Stock in Q2 2017 and held it in 4 quarters.
  • Ameritas Investment Partners's Histogen Inc. Common Stock position peaked at $13K in Q1 2018.
  • 61 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2018.

Based on Ameritas Investment Partners's 13F filing for Q2 2018, filed 13 Aug 2018.